HPV & CMV THERAPEUTICS MARKET ANALYSIS
Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, by Drug Type (HPV Therapeutics (Immunomodulatory Agents, Keratolytic Agents, Anti-Neoplastic Agents, and Sinecatechins) and CMV Therapeutics (Ganciclovir/Valaganciclovir, Foscarnet, and Cidifovir), by Application (HPV Therapeutics- Genital warts, Cervical cancer, Epidermodysplasia Verrucifdormis, and Others) and (CMV Therapeutics-CMV Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026
Cytomegalovirus (CMV) infections spread through body fluids such as saliva, semen, breast milk, and urine. Signs and symptoms of the infections include, fatigue, fever, diarrhea, pneumonia, and hepatitis, shortness of breath, gastrointestinal ulceration, and bleeding.
Although no treatment for the infection caused by human papillomavirus (HPV) is available, symptoms can be treated. Most sexually active men and women suffer from HPV infections. The infections spread through oral, vaginal or anal sex. HPV can also be transmitted during birth to infant and can lead to genital or respiratory infections.
Market Dynamics
Increasing collaboration activities of major players is expected to propel growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in November 2018, GeoVax Labs Inc. announced collaboration with Virometix. The collaboration focuses on development of therapeutic vaccines for HPV infections. This collaboration will include preclinical animal testing of GeoVax’s MVA-Vectored HPV vaccines candidates in combination with Virometix synthetic HPV vaccines candidates.
Moreover, increasing regulatory approvals for novel therapies is expected to boost the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth. For instance, in November 2017, Merck received the U.S. Food and Drug Administration approval for its Prevymis (letermovir) tablets and intravenous (IV) injection for prophylaxis of CMV infections and CMV seropositive recipients.
Key features of the study:
- This report provides in-depth analysis of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, , Allergan, Bausch Health, GlaxoSmithKline, Lee’s Pharmaceutical Holdings, Merck Sharp & Dohme, Fougera Pharmaceuticals, Clinigen Group plc., Perrigo Company plc., Roche Holding AG, Biotest AG, and Fresenius Kabi
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts
Request the sample copy here:
https://www.coherentmarketinsights.com/insight/request-sample/2707
Request the pdf brochure here:
https://www.coherentmarketinsights.com/insight/request-pdf/2707
Detailed Segmentation:
- Global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Application:
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- By Application
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- By Application
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- By Application
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- By Application
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- By Application
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Drug Type:
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- By Application
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Company Profiles
- GlaxoSmithKline*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Allergan
- Bausch Health
- Lee’s Pharmaceutical Holdings
- Merck Sharp & Dohme
- Fougera Pharmaceuticals
- Clinigen Group plc.
- Perrigo Company plc.
- Roche Holding AG
- Biotest AG
- Fresenius Kabi
Buy now the market research report here:
https://www.coherentmarketinsights.com/insight/buy-now/2707
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
- Customized market research service
- Industry analysis services
- Business consulting services
- Market intelligence services
- Long term engagement model
- Country specific analysis
Mr. shah
Coherent Market Insights Pvt. Ltd.
Address: Â Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Email:Â [email protected]